$15.2M Valsartan, Losartan & Irbesartan Contamination Settlement, Are You Eligible? Claim Deadline is June 2, 2026

Three pharmaceutical manufacturers — Aurobindo, Hetero, and Vivimed — agreed to pay a combined $15.2 million to settle claims that their blood pressure medications were contaminated with cancer-causing substances. If you paid for irbesartan, valsartan, or losartan manufactured by these companies at any point since 2016, you may qualify for a cash payment. The claim deadline is June 2, 2026.

Quick Facts

Field	Detail
Settlement Amount	$15,264,489.80 (combined)
Claim Deadline	June 2, 2026
Who Qualifies	U.S. consumers who paid for Aurobindo irbesartan (since Jan. 1, 2016), Hetero valsartan (May 1–July 31, 2018), or Vivimed losartan (specific NDCs)
Payout Per Person	Up to $200 (Aurobindo); up to $120 (Hetero); TBD (Vivimed)
Proof Required	Yes — pharmacy receipts or purchase documentation recommended
Settlement Status	Preliminarily approved; Final Hearing June 30, 2026
Administrator	Sartan Medication Settlement Administrator
Official Website	SartanMedicationSettlement.com

Current Status & What Happens Next

• The court has preliminarily approved all three settlements. The final approval hearing is scheduled for June 30, 2026.
• The deadline to file a claim, opt out, or object to the Aurobindo and Hetero settlements is June 2, 2026. Deadlines for the Vivimed settlement are set on the same date.
• Payments will go out after the court grants final approval, likely sometime after June 30, 2026. No exact payment date has been confirmed yet.

What Is the Valsartan, Losartan & Irbesartan Lawsuit About?

Aurobindo agreed to a $2 million settlement, Hetero agreed to an $11,365,489.80 settlement, and Vivimed agreed to a $1,899,000 settlement to resolve claims that their irbesartan, valsartan, and losartan blood pressure medications were contaminated with cancer-causing substances.

The class action alleged that medications from Aurobindo (irbesartan), Hetero (valsartan), and Vivimed (losartan) were contaminated with nitrosamine impurities — NDEA, NDMA, and NMBA, respectively — all alleged to be human carcinogens. Nitrosamines are chemical compounds that the FDA and international health agencies classify as probable human carcinogens.

The plaintiffs argued that each manufacturer knew or should have known that its medication contained these impurities, but allegedly failed to warn consumers and retailers about the contamination. As a result, consumers overpaid for medications they received that were not what was represented. Aurobindo, Hetero, and Vivimed have each denied any wrongdoing but agreed to resolve these allegations through their respective settlements.

Related article: $8.5M Virgin Galactic Securities Class Action Lawsuit Settlement, Did You Lose Money on SPCE Stock? Deadline to File a Claim is August 13

Who Is Eligible to File a Claim?

You may qualify for the Aurobindo (Irbesartan) settlement if:

• You are an individual in the United States or its territories
• You paid any amount for retail purchases of irbesartan finished drug formulations manufactured using Aurobindo’s IC Route of Synthesis (IC ROS) API
• Your purchases occurred from January 1, 2016 to the present

You may qualify for the Hetero (Valsartan) settlement if:

• You are an individual in the United States or its territories
• You paid any amount for retail purchases of valsartan formulations using Hetero Process III API
• Your purchases occurred between May 1, 2018 and July 31, 2018

You may qualify for the Vivimed (Losartan) settlement if:

• You are an individual in the United States or its territories
• You paid any amount for retail purchases of losartan finished drug formulations sold under one of these specific National Drug Codes (NDCs): 23155-644-09; 23155-644-10; 23155-645-03; 23155-645-09; 23155-645-10; 23155-646-03; 23155-646-09; or 23155-646-10

Not sure which NDC applies to you? Check the label on your medication bottle or contact your pharmacy. The NDC appears as an 11-digit number on all prescription drug packaging.

How Much Can You Receive?

Payouts differ across the three settlements based on which medication you took:

Aurobindo – Irbesartan Class members who paid out of pocket can receive a reimbursement of up to $100. Class members who have documentation of their purchases can receive a larger reimbursement of up to $200.

Hetero – Valsartan Consumers can generally receive up to $40 for each 30-day supply purchased, with a maximum total payment of $120. However, consumers who can sufficiently document purchases in excess of $40 for a 30-day supply may receive a higher payment without regard to the standard caps.

Vivimed – Losartan Payment amounts for individual Vivimed class members have not yet been specified, as the allocation method is to be determined by class counsel and reviewed by the court prior to the final approval hearing.

All payouts are subject to pro-rata reduction — meaning if total valid claims exceed the fund amount, each payment may be reduced proportionally. Submitting documentation increases both the amount you can claim and the likelihood your claim gets approved at the higher tier.

How to File a Claim

Step 1 — Visit the official claim portal at sartanmedicationsettlement.pnclassaction.com

Step 2 — Select which settlement applies to you: Aurobindo (irbesartan), Hetero (valsartan), or Vivimed (losartan)

Step 3 — Enter your personal details, including name, address, and contact information

Step 4 — Provide your purchase information — dates, quantities, and the medication you purchased

Step 5 — Upload proof of purchase if available (pharmacy receipts, insurance statements, or prescription records)

Step 6 — Submit your claim and save or screenshot your confirmation number

Estimated time to complete: 5–10 minutes

You can also download a paper claim form from the settlement website and submit it by mail to:

Sartan Medication Settlement Administrator P.O. Box 3376 Baton Rouge, LA 70821 Phone: 866-875-9644

Important Deadlines & Dates

Milestone	Date
Case Filed	2019 (MDL No. 2875)
Claims Period Opens	Open now
Claim Filing Deadline	June 2, 2026
Opt-Out Deadline	June 2, 2026
Objection Deadline	June 2, 2026
Final Approval Hearing	June 30, 2026
Expected Payment Date	TBD (after June 30, 2026)

Frequently Asked Questions

Do I need a lawyer to file a claim? 

No. You do not need a lawyer to file a claim in this settlement. The claim form is available online at SartanMedicationSettlement.com and takes about 5–10 minutes to complete. Filing is free and no attorney is required.

Is this settlement legitimate?

 Yes. This settlement is part of a federal class action — In re: Valsartan, Losartan and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875 — pending in the U.S. District Court for the District of New Jersey. The official settlement website is supervised by court-appointed counsel.

When will I receive my payment?

 Payments will process after the court grants final approval at the June 30, 2026 hearing. No exact payment date has been confirmed. Settlement checks typically mail within 3–6 months of final approval.

What if I missed the claim deadline? 

If you do not file by June 2, 2026, you will not receive a payment. You will still be bound by the settlement and cannot separately sue the defendants for the same claims, so filing before the deadline is critical.

Will this settlement payment affect my taxes? 

Settlement payments that reimburse you for out-of-pocket medical expenses are generally not taxable income. However, tax treatment depends on your individual situation. Consult a tax professional if you have specific questions.

What is a nitrosamine impurity, and is it dangerous?

 Nitrosamines are chemical byproducts that can form during pharmaceutical manufacturing. The FDA classifies NDMA, NDEA, and NMBA — the specific impurities alleged in this case — as probable human carcinogens. The contamination prompted widespread recalls of affected blood pressure medications starting in 2018.

What if I do not have a receipt for my medication? 

You can still file a claim without documentation, but your maximum payout will be lower. For the Aurobindo settlement, undocumented claims cap at $100; documented claims cap at $200. For Hetero, documented claims above $40 per 30-day supply can exceed the standard caps. Pharmacy printouts and insurance explanation-of-benefits statements both qualify as proof.

Can I opt out of the settlement and sue on my own?

 Yes. If you exclude yourself by June 2, 2026, you retain the right to bring your own lawsuit. However, you will not receive any payment from this settlement. Opting out makes sense only if you believe your individual damages significantly exceed what the settlement offers.

Sources & References

• Official Settlement Website: SartanMedicationSettlement.com
• Court Docket: In re: Valsartan, Losartan and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK, U.S. District Court, District of New Jersey

Last Updated: April 20, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.